Two Sigma Advisers’s Castlight Health CSLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-132,300
| Closed | -$204K | – | 3005 |
|
|
2021
Q4 | $204K | Sell |
132,300
-138,400
| -51% | -$228K | ﹤0.01% | 2282 |
|
|
2021
Q3 | $425K | Sell |
270,700
-643,600
| -70% | -$1.26M | ﹤0.01% | 1994 |
|
|
2021
Q2 | $2.4M | Buy |
914,300
+101,700
| +13% | +$189K | 0.01% | 1207 |
|
|
2021
Q1 | $1.23M | Buy |
812,600
+124,400
| +18% | +$216K | ﹤0.01% | 1535 |
|
|
2020
Q4 | $895K | Buy |
688,200
+186,900
| +37% | +$210K | ﹤0.01% | 1613 |
|
|
2020
Q3 | $566K | Buy |
501,300
+137,300
| +38% | +$151K | ﹤0.01% | 1756 |
|
|
2020
Q2 | $302K | Buy |
364,000
+204,200
| +128% | +$152K | ﹤0.01% | 2115 |
|
|
2020
Q1 | $116K | Buy |
159,800
+75,500
| +90% | +$84.1K | ﹤0.01% | 2283 |
|
|
2019
Q4 | $112K | Buy |
84,300
+52,600
| +166% | +$73.4K | ﹤0.01% | 2244 |
|
|
2019
Q3 | $45K | Sell |
31,700
-12,300
| -28% | -$24.5K | ﹤0.01% | 2157 |
|
|
2019
Q2 | $142K | Buy |
+44,000
| New | +$152K | ﹤0.01% | 2179 |
|
Two Sigma Advisers's CSLT Position: Q1 2022 in Review
Two Sigma Advisers sold out of Castlight Health (CSLT) in Q1 2022, closing a stake of 132,300 shares — an estimated $204K sold.
Two Sigma Advisers first reported a position in CSLT in Q2 2019 and held it in 11 quarters. The position peaked at $2.4M in Q2 2021. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.
- Two Sigma Advisers reported no remaining Castlight Health position as of Q1 2022 after selling out during the quarter.
- Two Sigma Advisers sold 132,300 Castlight Health shares in Q1 2022, an estimated $204K.
- Two Sigma Advisers first reported a position in Castlight Health in Q2 2019 and held it in 11 quarters.
- Two Sigma Advisers's Castlight Health position peaked at $2.4M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Castlight Health as of Q1 2022.
Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.